<DOC>
	<DOCNO>NCT01792648</DOCNO>
	<brief_summary>Metabolic syndrome include cluster cardiovascular disease ( CVD ) risk factor include insulin resistance , abdominal obesity , high blood pressure atherogenic lipoprotein phenotype characterize increased plasma triglyceride , low HDL-C , increase level small LDL particle . While lifestyle intervention remain cornerstone management , optimal dietary macronutrient distribution improve blood lipid CVD risk remain topic controversy . While low carbohydrate diet weight reduction effective manage atherogenic dyslipidemia , long-term compliance low , become imperative identify alternative dietary approach . Increased consumption almonds show low LDL-C , effect exceeds predict change fatty acid intake . However , although LDL-C lower almond demonstrated patient diabetes , trial non-diabetic patient metabolic syndrome . Moreover , limited information effect almond intake LDL particle subclass . The overall objective present study determine whether lipoprotein measure CVD risk individual metabolic syndrome reduce almond supplementation diet overall macronutrient content conforms current guideline . Our main hypothesis individual , almond consumption reduce level small medium LDL particles without need restrict dietary carbohydrate level currently recommend . This hypothesis test compare lipoprotein effect almond-supplemented diet ( 20 % E ) two reference diet contain almond product : one similar content carbohydrate , protein , fat ( standard reference ) , carbohydrate content reduce substitution protein monounsaturated fat ( low-carbohydrate reference ) . We provide diet 3 week randomize 3-period crossover design 40 individual atherogenic dyslipidemia metabolic syndrome . We test whether almond supplement diet result low level lipoprotein measure CVD risk , specifically LDL-C small medium LDL particle , compare either standard low-carbohydrate reference diet .</brief_summary>
	<brief_title>Effects Almond Intake Atherogenic Dyslipidemia Metabolic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<criteria>Age 20 old Plasma triglyceride ≥ 150mg/dL plasma HDLC &lt; 40 mg/dL ( men ) &lt; 50 mg/dL ( woman ) least one additional metabolic syndrome criterion : waist circumference &gt; 102 cm ( men ) &gt; 88 cm ( woman ) , blood pressure ≥ 130/≥ 85 mmHg , fast glucose ≥ 110mg/dL . Fasting blood sugar ( FBS ) &lt; 126 mg/dl Weight stable &gt; 3 month . History coronary heart disease , cerebrovascular disease , peripheral vascular disease , bleed disorder , liver renal disease , diabetes , lung disease , HIV , cancer ( skin cancer ) last 5 year . Taking hormones drug know affect lipid metabolism blood pressure . Systolic blood pressure &gt; 160 mm Hg diastolic blood pressure &gt; 95 mm Hg . Body mass index ( BMI ) &gt; 35 kg/m2 User nicotine product recreational drug Refusal abstain alcohol dietary supplement study . Total LDLC &gt; 95th percentile sex age . Fasting triglyceride &gt; 500 mg/dl Abnormal thyroid stimulate hormone ( TSH ) level . Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Almond</keyword>
	<keyword>Carbohydrate</keyword>
	<keyword>Diet</keyword>
	<keyword>Cholesterol</keyword>
</DOC>